Keros Therapeutics, Inc. — insider transactions
3 transactions on record · KROS · CIK 1664710
Aggregates
computed from the filings belowPurchases, 12m
2
count of open-market buys
Sales, 12m
1
count of open-market sales
Buy / sell ratio, 12m
2.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$20.9K
Sold, 3m
$46.2K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$46.2K
2026-08-18
Director share, 12m
66.7%
of transactions where role is stated
Current run
1 sells
consecutive same-direction transactions
Net 3m flow
-$25.3K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | 2026-08-18 | 2 | Cho Esther | Chief Legal Officer | Open market sale | 4,485 | $10.29 | $46.2K | filing |
| 2026-08-19 | 2026-08-17 | 2 | BIENAIME JEAN JACQUES | Director | Open market purchase | 1,000 | $10.27 | $10.3K | filing |
| 2026-07-17 | 2026-07-15 | 2 | BIENAIME JEAN JACQUES | Director | Open market purchase | 1,000 | $10.61 | $10.6K | filing |